Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
fibrocystic breast disease
MeSH D005348 - fibrocystic breast disease
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D001941:
Breast diseases
1 Company
1 Drug
$
Success rate
D005348:
Fibrocystic breast disease
4 Companies
1 Drug
$
Success rate
Events Timeline
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Sanofi
Danazol
Danocrine
1982-01-01
Barr Pharmaceuticals
Danazol
Danazol
1996-08-09
Lannett
Danazol
Danazol
2005-09-28
American Therapeutics
Danazol
Danazol
1987-12-30
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
0
%
0/2
Phase 3
100
%
1/1
Approved:
1
Overall Success rate:
0%
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use